Mulligan Mobilization vs Shockwave Therapy in Adhesive Capsulitis
NCT ID: NCT07310810
Last Updated: 2025-12-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
60 participants
INTERVENTIONAL
2025-05-01
2026-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Group A (study group) (n=20) will receive mulligan technique and conventional treatment.
* Group B (study group) (n=20) will receive extracorporeal shockwave therapy and conventional treatment.
* Group C (control group) (n=20) will receive conventional treatment only.
Inclusion criteria: patients that will be included in the study will be referred from orthopedic physician with:
1. Patients referred from orthopedist and diagnosed as frozen shoulder
2. The age of the participant will be from 40-60 (Agarwal S., et al.2016).
3. Body mass index from 25- 30 kg/m2.
4. having a painful stiff shoulder for at least 3 months
5. having limited ROM of a shoulder joint (ROM losses of 25% or greater compared with the noninvolved shoulder in at least 2 of the following shoulder motions: glenohumeral flexion, abduction and lateral rotation.
6. ability to complete Disabilities of the Arm, Shoulder and Hand questionnaires (DASH).
Exclusion criteria:
1. history of surgery on the particular shoulder
2. Rheumatoid arthritis
3. painful stiff shoulder after a severe trauma
4. fracture of the shoulder complex
5. rotator cuff rupture
6. tendon calcification.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
- Group A (study group)
received mulligan technique and conventional treatment
Mulligan mobilization
Mobilization with movement (MWM) is the concurrent application of sustained accessory mobilization applied by a therapist and an active physiological movement to end range applied by the patient. Passive end-of-range overpressure, or stretching, is then delivered without pain as a barrier
Conventional treatment
Conventional treatment will be axillary ultrasound and laser ,low loading stretching exercise and home program exercises
Group B (study group)
received extracorporeal shockwave therapy and conventional treatment.
Shockwave
From sitting with shoulder abducted at 45 degree and elbow flexed and the forearm rested on flat surface, The patients in the intervention group B received shock wave therapy once a week for 4 weeks. The focus probe sets were used and, in each session, patients received ESWT from anterior and posterior directions (on the average 1200 shocks between 0.1 and 0.3 mJ/mm2) up to the maximum threshold of pain tolerance in the shoulder
Conventional treatment
Conventional treatment will be axillary ultrasound and laser ,low loading stretching exercise and home program exercises
Group C (control group)
received conventional treatment only.
Conventional treatment
Conventional treatment will be axillary ultrasound and laser ,low loading stretching exercise and home program exercises
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Shockwave
From sitting with shoulder abducted at 45 degree and elbow flexed and the forearm rested on flat surface, The patients in the intervention group B received shock wave therapy once a week for 4 weeks. The focus probe sets were used and, in each session, patients received ESWT from anterior and posterior directions (on the average 1200 shocks between 0.1 and 0.3 mJ/mm2) up to the maximum threshold of pain tolerance in the shoulder
Mulligan mobilization
Mobilization with movement (MWM) is the concurrent application of sustained accessory mobilization applied by a therapist and an active physiological movement to end range applied by the patient. Passive end-of-range overpressure, or stretching, is then delivered without pain as a barrier
Conventional treatment
Conventional treatment will be axillary ultrasound and laser ,low loading stretching exercise and home program exercises
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ability to complete Disabilities of the Arm, Shoulder and Hand questionnaires (DASH).
Exclusion Criteria
40 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed Ragab Gaber
lecturer assistant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohamed R Gaber, Asst. lect.
Role: PRINCIPAL_INVESTIGATOR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Physical Therapy
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
012/005863
Identifier Type: -
Identifier Source: org_study_id